Search
for
Sort by
Research 901–930 of 1000+
- Biology of hair pigmentation and its role in premature canities
- Application of Baricitinib in Dermatology
- Retardation of Hair Follicle Development by the Deletion of TrkC, High-Affinity Neurotrophin-3 Receptor
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles
- Oil body bound oleosin-rhFGF9 fusion protein expressed in safflower (Carthamus tinctorius L.) stimulates hair growth and wound healing in mice
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Flavonoids and saponins: What have we got or missed?
- Epiregulin promotes hair growth via EGFR‐medicated epidermal and ErbB4‐mediated dermal stimulation
- Reductive Stress Selectively Disrupts Collagen Homeostasis and Modifies Growth Factor-independent Signaling Through the MAPK/Akt Pathway in Human Dermal Fibroblasts
- A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
- Safflower oil body nanoparticles deliver hFGF10 to hair follicles and reduce microinflammation to accelerate hair regeneration in androgenetic alopecia
- GDNF promotes hair formation and cutaneous wound healing by targeting bulge stem cells
- The trichoscopic features of hair shaft anomalies induced by epidermal growth factor receptor inhibitors: A case series
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- SPRY1 Deficiency in Keratinocytes Induces Follicular Melanocyte Stem Cell Migration to the Epidermis through p53/Stem Cell Factor/C-KIT Signaling
- The color of skin: white diseases of the skin, nails, and mucosa
- RE-ORGA, a Korean Herb Extract, Can Prevent Hair Loss Induced by Dihydrotestosterone in Human Dermal Papilla Cells
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Age‐associated decrease in GDNF and its cognate receptor GFRα‐1 protein expression in human skin
- Susan Lee Lindquist (1949–2016)—pioneer in the study of cellular protein folding and disease
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- 7410 Bevacizumab Induced Hypothyroidism